M. Garciaisidoro et al., CLINICAL AND BIOLOGICAL CHARACTERISTICS OF MYELODYSPLASTIC SYNDROMES WITH NULISOMY-Y BY FISH, Haematologica, 82(5), 1997, pp. 537-541
Background and Objective. In the present study we analyzed the inciden
ce of nulisomy Y by fluorescence in situ hybridization in a group of 2
4 males diagnosed with myelodysplastic syndromes (MDS). We explored th
e relationship between this chromosome abnormality and other clinical
and biological disease characteristics. Methods. Loss of chromosome Y
was present in 7 out of the 24 males analyzed (29%); the number of cel
ls carrying this chromosome aberration ranged between 19% and 90%. Fro
m the clinico-biological point of view, the group of patients with nul
isomy Y showed a higher incidence of RA and RAS FAB subtypes (p=0.04),
a lower WBC count (p=0.04), a lower proportion of blast cells both in
PB (p=0.009) and BM (p=0.06) associated with a decreased myeloid/eryt
hroid ratio (p=0.01). Results. No clear association was detected betwe
en loss of chromosome Y and other numerical chromosome abnormalities i
nvolving chromosomes 7 and 8. In contrast, 2 out of the 7 cases with l
oss of chromosome Y also displayed monosomy 1 by FISH. However, the us
e of appropriate dual stainings showed that these two abnormalities we
re present in different cell populations (that is, they never coexiste
d in the same cell population), which supports the notion of the exist
ence of clonal heterogeneity in MDS patients. Interpretation and Concl
usions. From the prognostic point of view, MDS patients with loss of c
hromosome Y displayed a higher survival rate, although these differenc
es did not reach statistical significance. (C) 1997, Ferrata Storti Fo
undation.